IL6 and hyperlipidemia: Systemically, the intervention effectively alleviated hyperglycemia, HOMA-IR, hyperlipidemia, and serum MDA levels, reduced NAS and liver TNF-α levels, while having no appreciable effect on adiposity, serum insulin levels, or liver IL-6, TG, and TC levels.